AJP - Lung Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
QUICK SEARCH:   [advanced]


     

Am J Physiol Lung Cell Mol Physiol (January 16, 2004). doi:10.1152/ajplung.00125.2003
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
286/6/L1122    most recent
00125.2003v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Maris, N. A.
Right arrow Articles by van der Poll, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Maris, N. A.
Right arrow Articles by van der Poll, T.
Submitted on April 28, 2003
Accepted on January 4, 2004

Salmeterol, a {beta}-2-receptor agonist, attenuates lipopolysaccharide-induced lung inflammation in mice

Nico A. Maris1*, Koenraad F. van der Sluijs1, Sandrine Florquin2, Alex F. de Vos1, Jennie M. Pater1, Henk M. Jansen3, and Tom van der Poll4

1 Department of Experimental Internal Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
2 Department of Pathology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
3 Department of Pulmonology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
4 Department of Experimental Internal Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands; Department of Infectious Diseases, Tropical Medicine and AIDS, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands

* To whom correspondence should be addressed. E-mail: n.a.maris{at}amc.uva.nl.

Lipopolysaccharide is ubiquitously present in the environment. To determine the effect of salmeterol, a long acting {beta}2-receptor agonist, on lipopolysaccharide- induced lung inflammation, mice received lipopolysaccharide (10 µg) intranasally with or without salmeterol intraperitoneally (5 mg/kg) 30 minutes earlier and 12 hours thereafter. Salmeterol dose and time dependently inhibited the lipopolysaccharide-induced influx of neutrophils into bronchoalveolar lavage fluid and lung tissue, and these pulmonary neutrophils displayed a reduced expression of CD11b at their surface. To determine the contribution of the salmeterol effect on neutrophil CD11b in the attenuated neutrophil recruitment, mice intranasally exposed to lipopolysaccharide were treated with salmeterol with or without a blocking anti-CD11b antibody. Anti-CD11b profoundly reduced lipopolysaccharide-induced neutrophil influx in bronchoalveolar lavage fluid , an effect that was modestly enhanced by concurrent salmeterol treatment. These data suggest that salmeterol inhibits lipopolysaccharide-induced neutrophil recruitment to the lungs by a mechanism that possibly in part is mediated by an effect on neutrophil CD11b.




This article has been cited by other articles:


Home page
 Eur Respir JHome page
C-H. Hung, Y-T. Chu, Y-M. Hua, S-H. Hsu, C-S. Lin, H-C. Chang, M-S. Lee, and Y-J. Jong
Effects of formoterol and salmeterol on the production of Th1- and Th2-related chemokines by monocytes and bronchial epithelial cells
Eur. Respir. J., June 1, 2008; 31(6): 1313 - 1321.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
C. W. Wieland, S. Florquin, and T. van der Poll
Interleukin 18 Participates in the Early Inflammatory Response and Bacterial Clearance during Pneumonia Caused by Nontypeable Haemophilus influenzae
Infect. Immun., October 1, 2007; 75(10): 5068 - 5072.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
P. J. Barnes
Scientific rationale for using a single inhaler for asthma control
Eur. Respir. J., March 1, 2007; 29(3): 587 - 595.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
X. Su, L. Robriquet, H. G. Folkesson, and M. A. Matthay
Protective effect of endogenous beta-adrenergic tone on lung fluid balance in acute bacterial pneumonia in mice
Am J Physiol Lung Cell Mol Physiol, April 1, 2006; 290(4): L769 - L776.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
S. Knapp, C. W. Wieland, S. Florquin, R. Pantophlet, L. Dijkshoorn, N. Tshimbalanga, S. Akira, and T. van der Poll
Differential Roles of CD14 and Toll-like Receptors 4and 2 in Murine Acinetobacter Pneumonia
Am. J. Respir. Crit. Care Med., January 1, 2006; 173(1): 122 - 129.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
N. A. Maris, A. F. de Vos, M. C. Dessing, C. A. Spek, R. Lutter, H. M. Jansen, J. S. van der Zee, P. Bresser, and T. van der Poll
Antiinflammatory Effects of Salmeterol after Inhalation of Lipopolysaccharide by Healthy Volunteers
Am. J. Respir. Crit. Care Med., October 1, 2005; 172(7): 878 - 884.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
P. J. Barnes and R. A. Stockley
COPD: current therapeutic interventions and future approaches
Eur. Respir. J., June 1, 2005; 25(6): 1084 - 1106.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
P. E. Parsons
Bridging the chasm between bench and bedside: translational research in acute lung injury
Am J Physiol Lung Cell Mol Physiol, June 1, 2004; 286(6): L1086 - L1087.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 2004 by the American Physiological Society.